Author:
Antoons Gudrun,Sipido Karin R.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference29 articles.
1. Zhang XP, Wu BW, Yang CH, et al. Dofetilide enhances the contractility of rat ventricular myocytes via augmentation of Na+–Ca2+ exchange. Cardiovasc Drugs Ther. 2009;23. This issue.
2. Gwilt M, Arrowsmith JE, Blackburn KJ, et al. UK-68, 798—A novel, potent and highly selective Class-iii antiarrhythmic agent which blocks potassium channels in cardiac cells. J Pharmacol Exp Ther. 1991;256:318–24.
3. Kiehn J, Villena P, Beyer T, et al. Differential effects of the new Class-III agent dofetilide on potassium currents in guinea-pig cardiomyocytes. J Cardiovasc Pharmacol. 1994;24:566–72.
4. Carmeliet E. Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther. 1992;262:809–17.
5. Camm AJ, Savelieva I. New antiarrhythmic drugs for atrial fibrillation: Focus on dronedarone and vernakalant. J Interv Card Electrophysiol. 2008;23:7–14.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献